These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 39009875)

  • 1. [Antiarrhythmic drugs in the present day].
    Allgaier R; Duncker D
    Inn Med (Heidelb); 2024 Aug; 65(8):762-769. PubMed ID: 39009875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].
    Pott C; Dechering DG; Muszynski A; Zellerhoff S; Bittner A; Wasmer K; Mönnig G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):228-38. PubMed ID: 21113605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A consensus report on antiarrhythmic drug use.
    Reiffel JA; Estes NA; Waldo AL; Prystowsky EN; DiBianco R
    Clin Cardiol; 1994 Mar; 17(3):103-16. PubMed ID: 8168278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac arrhythmia therapy.
    Vukmir RB
    Am J Emerg Med; 1995 Jul; 13(4):459-70. PubMed ID: 7605538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern pharmacotherapy of supraventricular and ventricular cardiac arrhythmia. An update for conventional therapy].
    Steven D; Lutomsky B; Rostock T; Willems S
    Internist (Berl); 2006 Oct; 47(10):1013-6, 1018-20, 1022-3. PubMed ID: 16988805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide. The Atrial Fibrillation Investigation with Bidisomide (AFIB) Investigators.
    Circulation; 1997 Oct; 96(8):2625-32. PubMed ID: 9355903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmia agents in heart failure].
    Duc P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol as an antiarrhythmic agent.
    Frieden J
    Am Heart J; 1967 Aug; 74(2):283-5. PubMed ID: 4951306
    [No Abstract]   [Full Text] [Related]  

  • 17. Are antiarrhythmic drugs obsolete?
    Tisdale JE; Webb CR
    Clin Pharm; 1992 Aug; 11(8):714-26. PubMed ID: 1511544
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP
    Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidysrhythmics. Emergent.
    Fulton S; Jackimczyk KC
    Emerg Med Clin North Am; 2000 Nov; 18(4):655-69. PubMed ID: 11130932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.